TABLE 1.

Changes in body weight and blood glucose level with resveratrol treatment

	Body weight (g)				Blood glucose (mmol/l)
	C-C	C-R	D-C	D-R	C-C	C-R	D-C	D-R
Week 0	28.3 ± 0.3	27.7 ± 0.5	21.2 ± 0.5	20.4 ± 0.4	8.7 ± 0.1	9.0 ± 0.3	25.4 ± 0.8	27.5 ± 0.9
Week 2	27.6 ± 0.3	26.3 ± 0.4	21.1 ± 0.6	21.1 ± 0.5	9.0 ± 0.2	7.4 ± 0.2	31.8 ± 0.7	29.6 ± 0.8
Week 4	28.5 ± 0.3	27.8 ± 0.4	20.6 ± 0.6	21.2 ± 0.5	8.3 ± 0.2	7.9 ± 0.2	31.2 ± 0.8	27.7 ± 1.2*

Data are means ± SE (n = 10). Resveratrol (in 0.5% CMC) at a dose of 20 mg/kg of body weight and 0.5% CMC alone were administered daily to control and diabetic mice, respectively, by oral gavage for 4 weeks. Time points were 0, 2, and 4 weeks after administration of resveratrol and CMC to control and diabetic mice, respectively, 1 month after STZ treatment: C-C and C-R, CMC- and resveratrol-treated control mice, respectively; D-C and D-R, CMC- and resveratrol-treated diabetic mice, respectively.

*P < 0.05 compared with CMC- and resveratrol-treated diabetic groups.